YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
16.00
+1.75 (12.28%)
At close: Sep 26, 2025, 4:00 PM EDT
16.38
+0.38 (2.37%)
After-hours: Sep 26, 2025, 7:45 PM EDT
YD Bio Market Cap
YD Bio has a market cap or net worth of $1.13 billion as of September 26, 2025. Its market cap has increased by 2,106.57% in one year.
Market Cap
1.13B
Enterprise Value
1.12B
1-Year Change
2,106.57%
Ranking
Category
Stock Price
$16.00
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $1.13B, an increase of 658.39%. That is a compound annual growth rate of 53.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 1.13B | 2,379.36% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | 144.79M | -2.40% |
| Dec 23, 2020 | 148.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 646.43B |
| Johnson & Johnson | 432.03B |
| AbbVie | 387.41B |
| UnitedHealth Group | 312.02B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.79B |
| AstraZeneca | 226.78B |